This special series on “The Actual Role of Percutaneous Transhepatic Biliary Interventions in The Orchestra of Digestive Disease Interventions” is edited by Dr. Daniel Schmitz, from University Campus of Hamburg Medical School, Schwerin, Germany.

Daniel Schmitz, MD
Department of Gastroenterology and Interventional Endoscopy, University Campus of Hamburg Medical School, Schwerin, Germany

Daniel Schmitz, MD, is the head physician of the Department of Gastroenterology and Interventional Endoscopy at University Campus of Hamburg Medical School in Schwerin, Germany. He has published several original articles and systematic reviews on percutaneous biliary interventions as on other issues of diagnostic and interventional endoscopy. He has received his medical education at University Hospital in Mainz, Germany, where he completed his doctoral thesis with the title “Systematic epitope characterization and quantitative analysis of cytotoxic T cells in the course of chronic hepatitis C" (Prof. Meyer zu Büschenfelde). He is member of the German Society for Digestive and Metabolic Diseases (DGVS), European Society of Gastrointestinal Endoscopy (ESGE), American Gastroenterological Association (AGA) and World Endoscopy Organization (WEO) and is working as trainer in endoscopic ultrasound as well as teacher at the Medical School of Hamburg.

Series outline:

1. Editorial: The actual role of percutaneous transhepatic biliary interventions in the orchestra of digestive disease interventions 
2. Percutaneous transhepatic therapy of biliary leaks: In which way and which indications? 
3. Preventive live tract sealing after percutaneous biliary interventions: How and when? 
4. Percutaneous-endoscopic rendezvous procedures for bile duct injuries 
5. Is there still a place for percutaneous transhepatic biliary drainage in malignant hilar obstruction? 
6. Percutaneous transhepatic biliary procedures to treat adverse events after liver transplantation 
7. Techniques to tackle the difficult bile duct access in percutaneous transhepatic biliary interventions 
8. Percutaneous transhepatic treatment of biliary stones: update on techniques and success rates 
9. Management of the most important adverse events in percutaneous transhepatic biliary interventions 
10. Indication and performance of salvage EUS-guided biliary drainage after failed percutaneous transhepatic biliary drainage

Disclosure:
The series “The Actual Role of Percutaneous Transhepatic Biliary Interventions in The Orchestra of Digestive Disease Interventions” was commissioned by the editorial office, Digestive Medicine Research without any sponsorship or funding. Daniel Schmitz is serving as the unpaid Guest Editor for the series.